Agendia: The New Era of Genomic Testing in Early Stage Breast Cancer.

Learn how genomic assays predict the likelihood of treatment response to aide patient selection for neoadjuvant therapy.  Presented by Dr. Caroline Drukker, Moderated by Dr. Isabel Rubio (Industry Forum, EBCC March 20, 2024)

• #science_technology
• #breast_cancer
• #genomic_testing
• #mammaprint
• #blueprint
• #genomic_profiling
• #early_stage_breast_cancer